Abstract: The present invention relates to novel heteroaryl compounds of Formula (I) and their pharmaceutically acceptable salts, solvates, polymorphs, tautomers, atropisomers, optical and geometric isomers, prodrugs, or deuterated compounds including other possible isotopes thereof as inhibitors of PKMYT1 The present invention also provides the process of preparation of compounds of Formula (I) for treating cancer.
| # | Name | Date |
|---|---|---|
| 1 | 202547050283-STATEMENT OF UNDERTAKING (FORM 3) [26-05-2025(online)].pdf | 2025-05-26 |
| 2 | 202547050283-REQUEST FOR EXAMINATION (FORM-18) [26-05-2025(online)].pdf | 2025-05-26 |
| 3 | 202547050283-PRIORITY DOCUMENTS [26-05-2025(online)].pdf | 2025-05-26 |
| 4 | 202547050283-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [26-05-2025(online)].pdf | 2025-05-26 |
| 5 | 202547050283-FORM FOR SMALL ENTITY(FORM-28) [26-05-2025(online)].pdf | 2025-05-26 |
| 6 | 202547050283-FORM 18 [26-05-2025(online)].pdf | 2025-05-26 |
| 7 | 202547050283-FORM 1 [26-05-2025(online)].pdf | 2025-05-26 |
| 8 | 202547050283-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [26-05-2025(online)].pdf | 2025-05-26 |
| 9 | 202547050283-DECLARATION OF INVENTORSHIP (FORM 5) [26-05-2025(online)].pdf | 2025-05-26 |
| 10 | 202547050283-COMPLETE SPECIFICATION [26-05-2025(online)].pdf | 2025-05-26 |
| 11 | 202547050283-Proof of Right [23-07-2025(online)].pdf | 2025-07-23 |